LLY · News · 20260817N

VivoSim Collaboration Milestone

ELI LILLY & Co · 2026-08-17 · Importance 53 · Surprise 82

VivoSim Labs reported that Lilly made a $5 million payment connected with their collaboration involving human-based tissue models and AI-enabled toxicity testing. VivoSim is commercializing its NAMkind products in mainland China. The company expects fiscal 2027 revenue growth of more than 500%, a change exceeding the specified 10% materiality threshold.

Key facts